The hyperactivity of Akt3 has been observed in some cancers, including breast cancer41, melanoma42, ovarian cancer43, and hepatocellular carcinoma44, and it is involved in the progression of the above mentioned tumors by regulating different downstream targets. Here, AKT3 is linked to cancer.